Nuria Tubau Juni
Virginia Polytechnic Institute and State University
H-index: 15
North America-United States
Top articles of Nuria Tubau Juni
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Treating Autoimmune Diseases With LANCL2 Therapeutics: A Novel Immunoregulatory Mechanism for Patients With Ulcerative Colitis and Crohn’s Disease | Nuria Tubau-Juni Raquel Hontecillas Andrew J Leber Sameeksha S Alva Josep Bassaganya-Riera | 2023/11/2 | |
Oral Omilancor Treatment Ameliorates Clostridioides difficile Infection During IBD Through Novel Immunoregulatory Mechanisms Mediated by LANCL2 Activation | Inflammatory Bowel Diseases | Nuria Tubau-Juni Josep Bassaganya-Riera Andrew J Leber Sameeksha S Alva Raquel Hontecillas | 2024/1/1 |
Nlrx1 ligands | 2023/1/10 | ||
The M2 Pipeline: A Novel Tool for Rapidly Analyzing Host Metabolic Profiles from RNA-seq Data | Ryan Baker Josep Bassaganya-Riera Nuria Tubau-Juni Andrew J Leber Raquel Hontecillas | 2023/4/21 | |
Substituted imidazoles as PLXDC2 ligands | 2023/3/7 | ||
Modulation of colonic immunometabolic responses during Clostridioides difficile infection ameliorates disease severity and inflammation | Scientific Reports | Nuria Tubau-Juni Josep Bassaganya-Riera Andrew J Leber Sameeksha S Alva Ryan Baker | 2023/9/7 |
Plxdc2 ligands | 2023/6/22 | ||
Host metabolic reprogramming ameliorates disease severity and colitis during Clostridioides difficileinfection | The Journal of Immunology | Nuria Tubau-Juni Josep Bassaganya-Riera Andrew J Leber Sameeksha S Alva Ryan Baker | 2023/5/1 |
LABP-73: A Novel NLRX1 Ligand for the Treatment of Chronic Asthma | Journal of Allergy and Clinical Immunology | Andrew Leber Raquel Hontecillas Nuria Tubau-Juni Sarah Fitch Sameeksha Alva | 2022/2/1 |
Withdrawn: efficacy, safety, and tolerability of omilancor in a phase 2 randomized, double-blind, placebo-controlled trial of patients with ulcerative colitis | Andrew Leber Raquel Hontecillas Nuria Tubau-Juni Simon Lichtiger Josep Bassaganya-Riera | 2022/2/1 | |
Correction to: Efficacy, Safety, and Tolerability of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis | Inflammatory Bowel Diseases | Andrew Leber Raquel Hontecillas Nuria Tubau-Juni Simon Lichtiger Josep Bassaganya-Riera | 2022/12/1 |
Computational modeling of complex bioenergetic mechanisms that modulate CD4+ T cell effector and regulatory functions | npj Systems Biology and Applications | Ryan Baker Raquel Hontecillas Nuria Tubau-Juni Andrew J Leber Shiv Kale | 2022/11/22 |
BT-11 (omilancor), a first-in-class, topical therapeutic for psoriasis, ameliorates disease severity and inflammation through activation of LANCL2 pathway | The Journal of Immunology | Nuria Tubau-Juni Andrew Leber Raquel Hontecillas Jyoti Chauhan Josep Bassaganya-Riera | 2021/5/1 |
Nlrx1-Regulated Defense and Metabolic Responses to Aspergillus fumigatus Are Morphotype and Cell Type Specific | Frontiers in Immunology | Bridget Kastelberg Tariq Ayubi Nuria Tubau-Juni Andrew Leber Raquel Hontecillas | 2021/11/1 |
First-in-class topical therapeutic omilancor ameliorates disease severity and inflammation through activation of LANCL2 pathway in psoriasis | Scientific Reports | Nuria Tubau-Juni Raquel Hontecillas Andrew Leber Panita Maturavongsadit Jyoti Chauhan | 2021/10/6 |
PLXDC2 activation by PX-69 ameliorates rheumatoid arthritis through activation of novel immunometabolic mechanisms | The Journal of Immunology | Nuria Tubau-Juni Andrew Leber Panita Maturavongsadit Jyoti Chauhan Raquel Hontecillas | 2021/5/1 |
NLRX1 is a key regulator of immune signaling during invasive pulmonary aspergillosis | PLoS Pathogens | Bridget Kastelberg Nuria Tubau-Juni Tariq Ayubi Austin Leung Andrew Leber | 2020/9/21 |
Identification of new regulatory genes through expression pattern analysis of a global RNA-seq dataset from a Helicobacter pylori co-culture system | Scientific reports | Nuria Tubau-Juni Josep Bassaganya-Riera Andrew Leber Victoria Zoccoli-Rodriguez Barbara Kronsteiner | 2020/7/13 |
Abscisic acid enriched fig extract promotes insulin sensitivity by decreasing systemic inflammation and activating LANCL2 in skeletal muscle | Scientific Reports | Andrew Leber Raquel Hontecillas Nuria Tubau-Juni Victoria Zoccoli-Rodriguez Bret Goodpaster | 2020/6/26 |
Characterization of Regulatory Mechanisms in Mucosal Immunity by Systems Immunology | Nuria Tubau Juni | 2020/1/28 |
